Basic Information
RNALocate ID: RLID:11002634
RNA Symbol: hsa-miR-148b-3p
Localization: Microvesicle
RNA Information
RNA Name: hsa-miR-148b
RNA ID: miRBase:MIMAT0000759
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 23539611
Tissue/Cell Line: Seminal plasma
Method: Microarray
Description: In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01002065 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:01002066 Mitochondrion Cell line (HEK-293|HeLa) 22984580
RLID:11002627 Exosome Primary dendritic cells|T cell line (J77) 21505438
RLID:11002628 Exosome Brain tissue 23382797
RLID:11002629 Exosome Plasma 23663360
RLID:11002630 Exosome Human mast cell line (HMC-1) 24009880
RLID:11002631 Extracellular vesicle HEK-293T cells 22849433
RLID:11002632 Microvesicle Plasma 19951903
RLID:11002633 Microvesicle Plasma 23077538
RLID-D:11000133 Exosome Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Mast cells|Tongue tissue
RLID-D:11000436 Microvesicle Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-148b-3p Splenic marginal zone lymphoma MNDR-E-MI-16098
MNDR hsa-miR-148b-3p Oral squamous cell carcinoma MNDR-E-MI-16099
MNDR hsa-miR-148b-3p Medulloblastoma MNDR-E-MI-16100
MNDR hsa-miR-148b-3p Uterine corpus endometrial carcinoma MNDR-E-MI-16101
MNDR hsa-miR-148b-3p Lymphoma MNDR-E-MI-16102
MNDR hsa-miR-148b-3p Lymphoma non-hodgkin MNDR-E-MI-16103
MNDR hsa-miR-148b-3p Estrogen-receptor positive breast cancer MNDR-E-MI-16104
MNDR hsa-miR-148b-3p Estrogen-receptor negative breast cancer MNDR-E-MI-16105
MNDR hsa-miR-148b-3p Progesterone-receptor positive breast cancer MNDR-E-MI-16106
MNDR hsa-miR-148b-3p Progesterone-receptor negative breast cancer MNDR-E-MI-16107
MNDR hsa-miR-148b-3p Breast cancer luminal MNDR-E-MI-16108
MNDR hsa-miR-148b-3p Dermatomyositis MNDR-E-MI-16109
MNDR hsa-miR-148b-3p Prostate cancer MNDR-E-MI-16110
MNDR hsa-miR-148b-3p Gastric cancer MNDR-E-MI-16111
MNDR hsa-miR-148b-3p Gastric lymphoma MNDR-E-MI-16112
MNDR hsa-miR-148b-3p Alzheimer disease MNDR-E-MI-16113
MNDR hsa-miR-148b-3p Intracranial aneurysm MNDR-E-MI-16114
MNDR hsa-miR-148b-3p Dysautonomia familial MNDR-E-MI-16115
MNDR hsa-miR-148b-3p Leukemia MNDR-E-MI-16116
MNDR hsa-miR-148b-3p Huntington disease MNDR-E-MI-16117
MNDR hsa-miR-148b-3p Chorea MNDR-E-MI-16118
MNDR hsa-miR-148b-3p Cardiovascular disease MNDR-E-MI-16119
MNDR hsa-miR-148b-3p Lung cancer MNDR-E-MI-16120
MNDR hsa-miR-148b-3p Fragile x syndrome MNDR-E-MI-16121
MNDR hsa-miR-148b-3p Parkinson disease MNDR-E-MI-16122
MNDR hsa-miR-148b-3p Breast cancer MNDR-E-MI-16123
MNDR hsa-miR-148b-3p Pancreatic cancer MNDR-E-MI-16124
MNDR hsa-miR-148b-3p Melanoma MNDR-E-MI-16125
MNDR hsa-miR-148b-3p Gaucher disease MNDR-E-MI-16126
MNDR hsa-miR-148b-3p Colon cancer MNDR-E-MI-16127
MNDR hsa-miR-148b-3p Multiple sclerosis relapsing-remitting MNDR-E-MI-16128
MNDR hsa-miR-148b-3p Hematologic cancer MNDR-E-MI-16129
MNDR hsa-miR-148b-3p Iga glomerulonephritis MNDR-E-MI-16130
MNDR hsa-miR-148b-3p Carcinoma ductal breast MNDR-E-MI-16131
MNDR hsa-miR-148b-3p Glioblastoma MNDR-E-MI-16132
MNDR hsa-miR-148b-3p Glioma MNDR-E-MI-16133
MNDR hsa-miR-148b-3p Nemaline myopathy MNDR-E-MI-16134
MNDR hsa-miR-148b-3p Amyotrophic lateral sclerosis MNDR-E-MI-16135
MNDR hsa-miR-148b-3p Osteosarcoma MNDR-E-MI-16136
MNDR hsa-miR-148b-3p Liposarcoma MNDR-E-MI-16137
MNDR hsa-miR-148b-3p Meningioma MNDR-E-MI-16138
MNDR hsa-miR-148b-3p Lung squamous cell carcinoma MNDR-E-MI-16139
MNDR hsa-miR-148b-3p Lung adenocarcinoma MNDR-E-MI-16140
MNDR hsa-miR-148b-3p Thyroid carcinoma MNDR-E-MI-16141
MNDR hsa-miR-148b-3p Bladder urothelial carcinoma MNDR-E-MI-16142
MNDR hsa-miR-148b-3p Pancreatic adenocarcinoma MNDR-E-MI-16143
MNDR hsa-miR-148b-3p Carcinoma renal cell MNDR-E-MI-16144
MNDR hsa-miR-148b-3p Kidney renal papillary cell carcinoma MNDR-E-MI-16145
MNDR hsa-miR-148b-3p Cholangiocarcinoma MNDR-E-MI-16146
MNDR hsa-miR-148b-3p Liver cirrhosis MNDR-E-MI-16147
MNDR hsa-miR-148b-3p Lung small cell carcinoma MNDR-E-MI-16148
MNDR hsa-miR-148b-3p Synovial sarcoma MNDR-E-MI-16149
MNDR hsa-miR-148b-3p Head and neck squamous cell carcinoma MNDR-E-MI-16150
MNDR hsa-miR-148b-3p Fibromyalgia MNDR-E-MI-16151
MNDR hsa-miR-148b-3p Breast invasive carcinoma MNDR-E-MI-16152
MNDR hsa-miR-148b-3p Early hepatocellular carcinoma MNDR-E-MI-16153
MNDR hsa-miR-148b-3p Rheumatoid arthritis MNDR-E-MI-16154
MNDR hsa-miR-148b-3p Hodgkin lymphoma MNDR-E-MI-16155
MNDR hsa-miR-148b-3p Tonsil cancer MNDR-E-MI-16156
MNDR hsa-miR-148b-3p Neuromyelitis optica MNDR-E-MI-16157
MNDR hsa-miR-148b-3p Skin cutaneous melanoma MNDR-E-MI-16158
MNDR hsa-miR-148b-3p Skin melanoma MNDR-E-MI-16159
MNDR hsa-miR-148b-3p Acute myelocytic leukemia MNDR-E-MI-16160
MNDR hsa-miR-148b-3p Gastrointestinal stromal tumor MNDR-E-MI-16161
MNDR hsa-miR-148b-3p Colorectal cancer MNDR-E-MI-16162
MNDR hsa-miR-148b-3p Nasopharynx carcinoma MNDR-E-MI-16163
MNDR hsa-miR-148b-3p Nasopharyngeal cancer MNDR-E-MI-16164
MNDR hsa-miR-148b-3p Prostatic neoplasms MNDR-E-MI-16165
MNDR hsa-miR-148b-3p Epstein-barr virus infections MNDR-E-MI-16166
MNDR hsa-miR-148b-3p Stroke lacunar MNDR-E-MI-16167
MNDR hsa-miR-148b-3p High grade dysplastic nodule MNDR-E-MI-16168
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ACACB Homo sapiens RR00032414
TOP